HEPATIC ENCEPHALOPATHY MARKET ANALYSIS

Hepatic Encephalopathy Market, by Drug Class (Antibiotics, Laxatives, L-ornithine L-aspartate, and others), by Route of administration (Oral, Intravenous, Rectal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : May 2023
Code : CMI2596
Pages :210
Formats :
Excel and PDF
Industry : Pharmaceutical

Regional Analysis

Global Hepatic Encephalopathy Market - Regional Analysis

Among all regions, North America is expected to dominate the global market over the forecast period. This is attributed to North America holding a 34.8% market share and due to presence of major players such as ASKA Pharmaceutical Co., Ltd., Cosmo Pharmaceuticals N.V, Lupin Limited., Kaleido Biosciences., and others are contributing for development of Hepatic Encephalopathy market.

The European region is expected to be second dominating region over the forecast period, due to increase in cirrhosis and liver failure. For instance, September, 2021 according to the National Center of Biotechnology and Information and clinical liver disease (CLD), cirrhosis is a leading cause of mortality and morbidity across the world. It is the 11th leading cause of death and 15th leading cause of morbidity, accounting for 2.2% of deaths and 1.5% of disability-adjusted life years worldwide in 2016. 1 CLD caused 1.32 million deaths, approximately two-thirds among men and one-third among women.